2025

Targeting TROP2 in aggressive variant and neuroendocrine prostate cancer.
Amsberg G, Kaune M, Bergmann L, Busenbender T, Strewinsky N, Paulsen F, Dum D, Tilki D, Graefen M, Bokemeyer C, Werner S, Dyshlovoy S
J CLIN ONCOL. 2025;43:171-171.

Transcriptional profiles of circulating tumor cells reflect heterogeneity and treatment resistance in advanced prostate cancer
Bergmann L, Greimeier S, Riethdorf S, Rohlfing T, Kaune M, Busenbender T, Strewinsky N, Dyshlovoy S, Joosse S, Peine S, Pantel K, von Amsberg G, Werner S
J EXP CLIN CANC RES. 2025;44(1):111.

6-((1,4-naphthoquinone-2-yl)methyl)thio-glucose conjugates, a novel targeted approach for advanced prostate cancer
Busenbender T, Pelageev D, Hauschild J, Kaune M, Boeckelmann L, Krisp C, Elsesy M, Zielinski A, Mair T, Riedner M, Moustafa A, Venz S, Kriegs M, Hoffer K, Sabutski Y, Borisova K, Strewinsky N, Kovach S, Khmelevskaya E, Schlüter H, Anufriev V, Tilki D, Graefen M, Mansour W, Bokemeyer C, Dyshlovoy S, von Amsberg G
MOL CANCER THER. 2025.

Abstract 5741: 6-((1,4-naphthoquinone-2-yl)methyl)thio-glucose conjugates, a novel targeted approach for advanced prostate cancer
Dyshlovoy S, Busenbender T, Pelageev D, Hauschild J, Kaune M, Böckelmann L, Krisp C, Elsesy M, Zielinski A, Mair T, Venz S, Kriegs M, Hoffer K, Sabutski Y, Borisova K, Strewinsky N, Kovach S, Khmelevskaya E, Pantel K, Schlüter H, Anufriev V, Tilki D, Graefen M, Mansour W, Bokemeyer C, Amsberg G
CANCER RES. 2025;85(8_Supplement_1):.

Aggressive Varianten und transdifferenziertes neuroendokrines Prostatakarzinom: Von der Diagnose zur Therapie
von Amsberg G, Dyshlovoy S, Kaune M
UROLOGE. 2025;64(3):246-255.

Debate 3: Oligometastatic Hormone Sensitive Prostate Cancer Management: Systemic Therapy Approach
von Amsberg G, Kaune M, Coym A, Strewinsky N, Falkenbach F, Hohenhorst J, Tilki D, Dyshlovoy S
SEMIN RADIAT ONCOL. 2025;35(3):433-438.

2024

Das fortgeschrittene Nierenzellkarzinom – Aktuelle Systemtherapie im Überblick
Kaune M, Bokemeyer C, von Amsberg G
DEUT MED WOCHENSCHR. 2024;149(4):180-190.

2023

Rhizochalinin Exhibits Anticancer Activity and Synergizes with EGFR Inhibitors in Glioblastoma In Vitro Models
Dyshlovoy S, Hauschild J, Venz S, Krisp C, Kolbe K, Zapf S, Heinemann S, Fita K, Shubina L, Makarieva T, Guzii A, Rohlfing T, Kaune M, Busenbender T, Mair T, Moritz M, Poverennaya E, Schlüter H, Serdyuk V, Stonik V, Dierlamm J, Bokemeyer C, Mohme M, Westphal M, Lamszus K, von Amsberg G, Maire C
MOL PHARMACEUT. 2023;20(10):4994-5005.

2022

Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer
Amsberg G, Zilles M, Mansour W, Gild P, Alsdorf W, Kaune M, Böckelmann L, Hauschild J, Krisp C, Rohlfing T, Saygi C, Alawi M, Zielinski A, Langebrake C, Su X, Perner S, Tilki D, Schluter H, Graefen M, Dyshlovoy S, Bokemeyer C
INT J MOL SCI. 2022;23(23):.

Immunotherapy in Advanced Prostate Cancer-Light at the End of the Tunnel?
von Amsberg G, Alsdorf W, Karagiannis P, Coym A, Kaune M, Werner S, Graefen M, Bokemeyer C, Merkens L, Dyshlovoy S
INT J MOL SCI. 2022;23(5):.

Study of Structure-Activity Relationships of the Marine Alkaloid Fascaplysin and Its Derivatives as Potent Anticancer Agents
Zhidkov M, Kaune M, Kantemirov A, Smirnova P, Spirin P, Sidorova M, Stadnik S, Shyrokova E, Kaluzhny D, Tryapkin O, Busenbender T, Hauschild J, Rohlfing T, Prassolov V, Bokemeyer C, Graefen M, von Amsberg G, Dyshlovoy S
MAR DRUGS. 2022;20(3):.

2021

Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer Cells
Dyshlovoy S, Pelageev D, Jakob L, Borisova K, Hauschild J, Busenbender T, Kaune M, Khmelevskaya E, Graefen M, Bokemeyer C, Anufriev V, von Amsberg G
PHARMACEUTICALS-BASE. 2021;14(10):949.

2020

Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer Cells
Dyshlovoy S, Kaune M, Hauschild J, Kriegs M, Hoffer K, Busenbender T, Smirnova P, Zhidkov M, Poverennaya E, Oh-Hohenhorst S, Spirin P, Prassolov V, Tilki D, Bokemeyer C, Graefen M, von Amsberg G
MAR DRUGS. 2020;18(12):.

Marine alkaloid monanchoxymycalin C: a new specific activator of JNK1/2 kinase with anticancer properties
Dyshlovoy S, Kaune M, Kriegs M, Hauschild J, Busenbender T, Shubina L, Makarieva T, Hoffer K, Bokemeyer C, Graefen M, Stonik V, von Amsberg G
SCI REP-UK. 2020;10(1):13178.

Urupocidin C: a new marine guanidine alkaloid which selectively kills prostate cancer cells via mitochondria targeting
Dyshlovoy S, Kudryashova E, Kaune M, Makarieva T, Shubina L, Busenbender T, Denisenko V, Popov R, Hauschild J, Fedorov S, Bokemeyer C, Graefen M, Stonik V, von Amsberg G
SCI REP-UK. 2020;10(1):9764.

Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate Cancer
Dyshlovoy S, Pelageev D, Hauschild J, Sabutskii Y, Khmelevskaya E, Krisp C, Kaune M, Venz S, Borisova K, Busenbender T, Denisenko V, Schlüter H, Bokemeyer C, Graefen M, Polonik S, Anufriev V, Amsberg G
MAR DRUGS. 2020;18(5):.

Polyphenolic Compounds from Lespedeza Bicolor Root Bark Inhibit Progression of Human Prostate Cancer Cells via Induction of Apoptosis and Cell Cycle Arrest
Dyshlovoy S, Tarbeeva D, Fedoreyev S, Busenbender T, Kaune M, Veselova M, Kalinovskiy A, Hauschild J, Grigorchuk V, Kim N, Bokemeyer C, Graefen M, Gorovoy P, von Amsberg G
BIOMOLECULES. 2020;10(3):.

2019

Successful Targeting of the Warburg Effect in Prostate Cancer by Glucose-Conjugated 1,4-Naphthoquinones
Dyshlovoy S, Pelageev D, Hauschild J, Borisova K, Kaune M, Krisp C, Venz S, Sabutskii Y, Khmelevskaya E, Busenbender T, Denisenko V, Pokhilo N, Atopkina L, Graefen M, Schlüter H, Stonik V, Bokemeyer C, Anufriev V, von Amsberg G
CANCERS. 2019;11(11):.

Total Syntheses and Preliminary Biological Evaluation of Brominated Fascaplysin and Reticulatine Alkaloids and Their Analogues
Zhidkov M, Smirnova P, Tryapkin O, Kantemirov A, Khudyakova Y, Malyarenko O, Ermakova S, Grigorchuk V, Kaune M, Amsberg G, Dyshlovoy S
MAR DRUGS. 2019;17(9):.

Letzte Aktualisierung aus dem FIS: 28.08.2025 - 00:38 Uhr